Dusa Licenses Nicomide To Former Foe

Law360, New York (August 14, 2008, 12:00 AM EDT) -- Dusa Pharmaceuticals Inc. has agreed to license the rights to its acne treatment Nicomide to generics maker River's Edge Pharmaceuticals LLC, amending a settlement reached last year in the drugmakers' patent dispute.

Dusa entered into a nonexclusive patent license agreement that will allow River’s Edge to sell the Nicomide product in the prescription market.

River’s Edge adds the rights to Nicomide, formerly the cause of the litigation, to two exclusive licenses for skin creams Dusa granted under the settlement last year.

Dusa intends to sell Nicomide...
To view the full article, register now.